{"name":"Second Genome","slug":"second-genome","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPVWowYUVJcXdzMzI3RkwyVkRQNFAxeXpUTkVhSDhiTk1aQ29tamxPd25hWnU4ak9SUnZwbmQzSF9vWXZoRXFjX1h0RTZISjhXc3JMZS1MR3ExVWJzTDZ0ZWd4dENyTWFNRFFoWktRNlpPZUNieklmbnRVMm1IOEQtamhRVW5DVUYzUG9CUzBGQjJhdzJpbXpqaHpmclEzQQ?oc=5","date":"2026-03-13","type":"pipeline","source":"openPR.com","summary":"Human Microbiome Therapeutics Market to Reach US$4.16 Billion - openPR.com","headline":"Human Microbiome Therapeutics Market to Reach US$4.16 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPbHhkUWxWeHE3cW9jbndiQUZNeEVqd004bkxqSmdZY2lFM01NMmlsa0ZCZkRaeGIzSzdoaHJPalVZQm5VcDJLN1h2OTl4RGNUSVhzQ3Z1QnVJT3p2MEttYVhtUmo3TXp3RFJtRmgxa3V6bWlvY2NURlc4cHNwdlpGSTVRbU1xT2JIWVJob2Vtaw?oc=5","date":"2026-02-05","type":"pipeline","source":"The Motley Fool","summary":"Best Genomics Stocks of 2026: Are They Right for Your Portfolio? - The Motley Fool","headline":"Best Genomics Stocks of 2026: Are They Right for Your Portfolio?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPTTltQ0VMV3doOC1UZVp4cUdic3ptNkJOUENIMF9zdXBlYjZZTjdxYnNMOXdJQktRNnNVTGlaN0xpZld3eTJ1TmJGZlpkU2RNVmlWM1ZfdkdwTktUODItRmpta1hNSjM1MlRLMU8tOFZwNU1GOE1XaExDOGhQVHI2clJNc19JLWM2NEY0VGRJSm5janpM?oc=5","date":"2025-12-23","type":"pipeline","source":"Frontiers","summary":"Editorial: Genomic discoveries and pharmaceutical development in urologic tumors - volume II - Frontiers","headline":"Editorial: Genomic discoveries and pharmaceutical development in urologic tumors - volume II","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPWk53aEh6RkhxWmZXMTQ5WVpnNk41UjA1YVFsVVhhRkxycWIzTXIwWUNwem82X19URWN2NTd0REJ3V1oxNVI2cEZHWWhDUll1bC03amFaaGtOOG9qR3pjZTR1UGFFMGZoU3hxV19wTUotUlVIY1l0Rjgtem5ZWGNyLTlJaVJKNU42ZDJpcVdJLS1JcllUOTRheWZlelctSFRyb1ZKSmszZGxocElsTnc?oc=5","date":"2025-12-22","type":"pipeline","source":"Fierce Pharma","summary":"Samsung Biologics pays GSK $280M to secure first US manufacturing site - Fierce Pharma","headline":"Samsung Biologics pays GSK $280M to secure first US manufacturing site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWW1xM29PZDBmc0pYNGhYaW9KMkl2Y3ExQ0I2cVhNVkJSdlUxZ2NSVTZDYXZTMjJNVWVWbzRrOFlrSVJodU1NdDRLcmtoYUlVTmRBb2dMQjB6Z3F5ajZfaUx5T21xZllnTGtGVE8yVXg3ZFJGR0t1YUZjaUtPWGJZMEJEdkljRXBzN0dfX2hLbUhBRmhYcl90QXNxVldNS19RaTIyMDRZdVIwLW9wNkFsWXpXVkJZS1VMVFJuby1SN18xZw?oc=5","date":"2025-11-11","type":"pipeline","source":"Reuters","summary":"James Watson, co-discoverer of DNA's double helix, dead at 97 - Reuters","headline":"James Watson, co-discoverer of DNA's double helix, dead at 97","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1kNThzU1RrU09sakFCdlJaOXVVZnZhcjg2OXpIajhaMEk4N25DaF95YXo0Tk9ZakdYRl92bnBLcXZmdkZJaG1YZzVCSFVmSFRmdHpybHhTMEdVQTJQZFNDb1dXYzExZw?oc=5","date":"2025-10-30","type":"pipeline","source":"MedPage Today","summary":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC - MedPage Today","headline":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1RWURRenl6eE9SRjRnZWFZaWg2ZGg5U2FmeHNwR2FwazByODY1SmxjUmV6b0V0MFdna1BENXdQNk8yOFNLUm55cERUOEpaa3ZfUWl5TGxja0NGS2Y4YnRJ?oc=5","date":"2025-10-09","type":"regulatory","source":"Nature","summary":"Systematic over-expression of secondary metabolism transcription factors to reveal the pharmaceutical potential of Aspergillus nidulans - Nature","headline":"Systematic over-expression of secondary metabolism transcription factors to reveal the pharmaceutical potential of Asper","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE91bXBXb21Uei1jLVdOR2JCbVNSeG1FVlZEOUlXQjFHZkI3eW9qOTMycUZRZFZiaVNhUXpfalpZYkRIYUlVakVqU3pZY2xQenB0VWhYcnRKUTZOODRmMGc?oc=5","date":"2025-09-02","type":"pipeline","source":"Fierce Pharma","summary":"Eric Green - Fierce Pharma","headline":"Eric Green","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQMGpEcHo3N3ZYVVd6NDd6eUpwcUE1d3pub1ZkME4wVll5VjZ3a05TS0ZsajlQRXRXZVJKcWFrS1hMeXVJRVFvdDROZ3pCakoyV0EtMWRoRmZ5ZnU3QnlSR0U5ZF9iUXBTTExVUUJpUGlYVHJfWTBuZ3o1dmgtYVl5eFRjRV9lTmhBdlpoZVFNS1pWOGFRNDRKR1JMakY2NUxncnBsYVpXUnBLNmUwMWJSVlV3?oc=5","date":"2023-06-24","type":"pipeline","source":"Healthcare Brew","summary":"Microbiome therapeutics could be the next big thing in pharma - Healthcare Brew","headline":"Microbiome therapeutics could be the next big thing in pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPeWZlNmg5OWxMN1lpcjg1Wml4bExYa180NW5zQVFOejRPVzBBQmtReTV0OVlTZTh6YW5xWHFsZHdsV3laYmp4d19neUt2TEh0Ui1aY2d4X0tYQ3kzTWFvVFlHVll5eXZNamVFVmFIVG5wR3hUSVJQRnRnd1NGUXhSRzdnVEhNUHU3VXM0WFdxbUNxSC1fdHdLajVqWQ?oc=5","date":"2022-06-03","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"From Pharma to Farm: Can CRISPR Feed the World? - Genetic Engineering and Biotechnology News","headline":"From Pharma to Farm: Can CRISPR Feed the World?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQQzI3ejJUek0xM19FdFNvRUhMUmNLNVBpbTIzY2EwS0pWRHhxY3pVQVlIQ0IyNmNMblpnM1F5TnZhVDFIZkR2aElUUU1kWUFHdExyRjctM0hqVFNaN1lmQm9WckJ2bE1rMGp4WEt4YlhGd2JCWDNza0pxYXZLX0t5NGpHQmFwNk8tUU9GVEh6VGdtZw?oc=5","date":"2020-04-06","type":"pipeline","source":"BioPharma Dive","summary":"Gilead to lean on Second Genome’s microbiome work in $38M research pact - BioPharma Dive","headline":"Gilead to lean on Second Genome’s microbiome work in $38M research pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNbzFnVUQ4SDAtQ21fVkZwRjFfS2ItMUl3dDNmZXBtOUo3b0FpbGJFalNCTTVfTW1MS3FzRTUtdHRsUWd1cmdhT0U1V1R0bFNreS1FdkhqdUtiWlJUT1BmSVBKUEtwODZWMkVUUW9tZHFQNVFZRjJ2Q2NKTmlMS21EVFRRdEYyTTlCbmkwRUF5bUhtMm9rSndZeldKTG0ydDVMdjJhRzZWekdoS3Y3MjkyeHFsS0puNmpmMEVyWEVpMlZTdzVkNlhBc2I4T21xMlYtNDByazJrSGpQems?oc=5","date":"2019-04-09","type":"pipeline","source":"prnewswire.com","summary":"FORTUNE and Great Place to Work Name Second Genome a \"Top 10 Best Workplace in Biopharma\" - prnewswire.com","headline":"FORTUNE and Great Place to Work Name Second Genome a \"Top 10 Best Workplace in Biopharma\"","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}